- Dec 2, 2024
- 886
- 278
aasdirect.to
ACTIVE HALF-LIFE: 2 DAYS
CLASSIFICATION: NON-STEROIDAL AROMATASE INHIBITOR
DOSAGE: 0.5 – 2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOXITY: NO
AROMATIZATION: NO
Letrozole, manufactured by Bouwen, acts as an inhibitor of aromatase, an enzyme crucial in estrogen formation. Its mechanism of action involves inhibiting the cytochrome P450 genome within aromatase. Through extended use, the drug induces a reduction in estrogen activity by 75-95% from baseline.
Belonging to the third and latest generation of aromatase inhibitors, Letrozole shares similarity with Anastrozole but differs from Clomid and Nolvadex, which function as estrogen receptor blockers. Letrozole affects the production of estrogen itself, unlike the latter drugs that solely bind to estrogen receptors in the body.
ACTIVE HALF-LIFE: 2 DAYS
CLASSIFICATION: NON-STEROIDAL AROMATASE INHIBITOR
DOSAGE: 0.5 – 2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOXITY: NO
AROMATIZATION: NO
Letrozole, manufactured by Bouwen, acts as an inhibitor of aromatase, an enzyme crucial in estrogen formation. Its mechanism of action involves inhibiting the cytochrome P450 genome within aromatase. Through extended use, the drug induces a reduction in estrogen activity by 75-95% from baseline.
Belonging to the third and latest generation of aromatase inhibitors, Letrozole shares similarity with Anastrozole but differs from Clomid and Nolvadex, which function as estrogen receptor blockers. Letrozole affects the production of estrogen itself, unlike the latter drugs that solely bind to estrogen receptors in the body.
